Sitnilska V, Brocks U, Tode J, Spital G, Altay L. [Treatment of central serous chorioretinopathy in comparison-Micropulse laser versus photodynamic therapy].
DIE OPHTHALMOLOGIE 2025;
122:186-195. [PMID:
39920292 DOI:
10.1007/s00347-025-02183-0]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Revised: 12/20/2024] [Accepted: 01/08/2025] [Indexed: 02/09/2025]
Abstract
The therapeutic management of central serous chorioretinopathy (CSC) remains challenging. Although CSC shows a high rate of self-resorption, frequent recurrences or chronification of the disease can result in irreversible loss of vision. Low-dose photodynamic therapy (half-dose or half-fluence PDT) represents the current standard of care for CSC, although regenerative laser procedures may also offer a safe and effective alternative for the treatment of CSC.
Collapse